Equities

Intelligent Ultrasound Group PLC

IUG:LSE

Intelligent Ultrasound Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)11.75
  • Today's Change0.125 / 1.08%
  • Shares traded223.01k
  • 1 Year change+27.03%
  • Beta1.1445
Data delayed at least 20 minutes, as of Nov 21 2024 11:45 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Intelligent Ultrasound Group plc is an ultrasound company. It is specializing in real-time hi-fidelity virtual reality simulation for the ultrasound training market. It operates through the Simulation segment. Its main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid-19 module, and the new BabyWorks Neonate and Paediatric training simulator. ScanTrainer provides a learning curriculum in ultrasound across obstetrics, gynecology, general and emergency medicine. HeartWorks AR is a highly portable solution with the fidelity of the HeartWorks simulator. Bodyworks Eve is an ultra-realistic female patient simulator designed to meet the training needs of Point of Care Ultrasound (PoCUS) in emergency medicine and critical care scenarios. Its NeedleTrainer provides an all-in-one training solution to teach ultrasound-guided needling.

  • Revenue in GBP (TTM)8.64m
  • Net income in GBP-2.51m
  • Incorporated2014
  • Employees67.00
More ▼

Institutional shareholders

30.02%Per cent of shares held by top holders
HolderShares% Held
Octopus Investments Ltd.as of 31 Mar 202435.85m10.96%
Polar Capital LLPas of 31 Mar 202427.26m8.33%
Canaccord Genuity Wealth Ltd.as of 31 Mar 202413.77m4.21%
Herald Investment Management Ltd.as of 31 Mar 202411.45m3.50%
Rathbones Investment Management Ltd.as of 31 Mar 20249.88m3.02%
More ▼
Data from 30 Sep 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.